IMUC - ImmunoCellular Therapeutics, Ltd.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• IPO Roundup: Richtech Robotics, Triller and more
• EOM Pharmaceuticals shelves plans to uplist shares, raise $15M
• Eom Pharmaceuticals files for possible $25M IPO, changing name from Intercellular Therapeutics
• EOM Pharmaceuticals files to uplist to Nasdaq
• ImmunoCellular up 37% on asset sale
• FDA finalizes guidance for expedited review of cell and gene therapy applications
• Investors returning to tiny biotechs
• Bargain hunters move back into biotech
• ImmunoCellular Therapeutics to delist stock; shares down 73% after hours
• Investors shun healthcare stocks in broad market selloff
• ImmunoCellular Therapeutics reports Q2 results
• ImmunoCellular Therapeutics announces settlement terms of federal class action shareholder lawsuit
• ImmunoCellular Therapeutics reports Q1 results
• ImmunoCellular advances Stem-to-T-Cell technology; shares up 27% premarket
• ImmunoCellular Therapeutics receives audit opinion with going concern explanation
• ImmunoCellular Therapeutics reports FY results
• IntraCellular to review strategic alternatives; shares up 1%
• 2017 YTD worst losers - healthcare
• ImmunoCellular Therapeutics +158% on immuno-oncology milestone
• ImmunoCellular Therapeutics reports Q3 results